# SILEXION THERAPEUTICS CORP (SLXN)

> Institutional ownership reported to the SEC as of Q1 2026, from Form 13F filings. Source: https://holderbook.com/stocks/SLXN/

- Reporting holders: 7
- Reported value: $46.7K
- Shares held by institutions: 36,479 of 3,330,785 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $26.8K | 20,926 | 0.0% | 2 |
| [TWO SIGMA SECURITIES, LLC](https://holderbook.com/funds/1450144-two-sigma-securities-llc/) | $14.9K | 11,657 | 0.0% | 1 |
| [MONTAG A & ASSOCIATES INC](https://holderbook.com/funds/829407-montag-a-associates-inc/) | $3.8K | 3,000 | 0.0% | 3 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $662 | 517 | 0.0% | 3 |
| [Pflug Koory, LLC](https://holderbook.com/funds/1740063-pflug-koory-llc/) | $426 | 333 | 0.0% | 3 |
| [JONES FINANCIAL COMPANIES LLLP](https://holderbook.com/funds/815917-jones-financial-companies-lllp/) | $32 | 26 | 0.0% | 2 |
| [SBI Securities Co., Ltd.](https://holderbook.com/funds/1851815-sbi-securities-co-ltd/) | $26 | 20 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2026 | 7 | $46.7K |
| Q4 2025 | 6 | $35.2K |
| Q3 2025 | 4 | $17.3K |
| Q2 2025 | 8 | $258.1K |
| Q1 2025 | 5 | $259.8K |
| Q4 2024 | 3 | $280.8K |
| Q3 2024 | 5 | $612.8K |